z-logo
open-access-imgOpen Access
Effect of a Histamine H 2 Type Receptor Antagonist (WY 45, 727) on the Healing of Gastric Ulcers in Ponies
Author(s) -
MacAllister Charles G.,
Sangiah Subbiah,
Mauromoustakos Andy
Publication year - 1992
Publication title -
journal of veterinary internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.356
H-Index - 103
eISSN - 1939-1676
pISSN - 0891-6640
DOI - 10.1111/j.1939-1676.1992.tb00351.x
Subject(s) - medicine , stomach , histaminergic , placebo , histamine , antagonist , gastroenterology , oral administration , body weight , domperidone , anesthesia , receptor , pathology , dopamine , alternative medicine
Using video gastroscopy, the efficacy of a Histamine‐H 2 type receptor antagonist (WY 45, 727) was investigated in young ponies with spontaneous and experimentally induced gastric ulcers. Oral administration of WY 45,727 at 2 mg/kg and 10 mg/kg of body weight every 12 hours for 14 days resulted in complete healing of spontaneous gastric ulcers in the non‐glandular portion of the stomach in 2/5 (40%) and 3/4 (75%) of the ponies, respectively, compared ( P >0.05) to 0/5 (0%)placebo‐treated ponies. After intramuscular administration of flunixin meglumine at 1.5 mg/kg body weight every 8 hours for 6 days, 9/18 ponies had ulcers in the non‐glandular portion of the stomach. Oral administration of WY 45,727 at 10 mg/kg body weight every 12 hours for 14 days resulted in complete healing of the non‐glandular gastric ulcers in 3/4 (75%) compared with ( P > 0.05) 1/5 (20%) placebo‐treated ponies. This study indicates that 1) the occurrence of subclinical ulcers may be common in young ponies; 2) flunixin meglumine at 1.5 mg/kg intramuscularly every 8 hours for 6 days may result in ulcers of the non‐glandular stomach in ponies; and 3) WY 45,727, a histaminergic H 2 type receptor antagonist could be of value in the therapeutic management of ulcers in the non‐glandular stomach of foals and adult horses. (Journal of Veterinary Internal Medicine 1992; 6:271–275)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here